Clinical Trial: A Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting Conditions

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901088) titled 'A Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting Conditions' on Oct. 22.

Brief Summary: To evaluate the bioequivalence and safety of AJU-B718 and B718R in Healthy Adults.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Peripheral Arterial Disease

Intervention: DRUG: Test Drug

AJU-B718

DRUG: Reference Drug

B718R

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AJU Pharm Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....